Skip to main content
SpringerLink
Log in

Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis

  • Conference paper
Chronic Viral and Inflammatory Cardiomyopathy

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 55))

Abstract

Myocarditis is most often induced by cardiotropic viruses and often resolves with minimal cardiac remodelling and without discernable prognostic impact. Acute myocarditis has a highly diverse clinical presentation (asymptomatic, infarct-like presentation, atrioventricular (AV)-block, atrial fibrillation, sudden death due to ventricular tachycardia, fulminant myocarditis with severely depressed contractility). Progression of myocarditis to its sequela, dilated cardiomyopathy (DCM), has been documented in 20% of cases and is pathogenically linked to chronic inflammation and viral persistence. Persistence of cardiotropic viruses (enterovirus, adenovirus) constitutes one of the predominant aetiological factors in DCM. Additionally, circulating autoantibodies to distinct cardiac autoantigens have been described in patients with DCM, providing evidence for autoimmune involvement. Since clinical complaints of myocarditis and DCM are unspecific, a positive effect of any specific therapy depends on an accurate biopsy-based diagnosis and characterization of the patients with histological, immunohistological and molecular biological methods (PCR), which have developed into sensitive tools for the detection of different viruses, active viral replication, and myocardial inflammation. The immunohistochemical characterization of infiltrates has supported a new era in the diagnosis of myocardial inflammation compared with the Dallas criteria, which has led to a new entity of secondary cardiomyopathies acknowledged by the WHO, the inflammatory cardiomyopathies (DCMi). Immunohistochemically quantified lymphocytes significantly better reflect troponin levels and correlate with findings by anti-myosin scintigraphy compared with the histological analysis. Furthermore, the orchestrated induction of endothelial cell adhesion molecules (CAMs) in 65% of DCM patients has confirmed that CAM induction is a prerequisite for lymphocytic infiltration in DCMi. The combination of these immunohistological with molecular biological diagnostic techniques of virus analysis allows a further classification of dilated cardiomyopathy by differentiating the disease entity in subgroups of virus-positive and virus-negative patients with or without cardiac inflammation. Further analysis of the predominant Th1-/Th2-immune response may provide additional prognostic information on the natural course of the disease. This differential analysis improves the clinical management of patients and is an indispensable prerequisite for the development of specific antiviral or immunomodulatory treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Angelini A, Crosato M, Boffa GM, Calabrese F, Calzolari V, Chioin R, Daliento L, Thiene G (2002) Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart 87:210–215

    Article  PubMed  CAS  Google Scholar 

  • Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464–470

    Article  PubMed  CAS  Google Scholar 

  • Baboonian C, Treasure T (1997) Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539–543

    PubMed  CAS  Google Scholar 

  • Bowles NE, Richardson PJ, Olsen EG, Archard LC (1986) Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1:1120–1123

    Article  PubMed  CAS  Google Scholar 

  • Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95

    Article  PubMed  Google Scholar 

  • Calabrese F, Thiene G (2003) Myocarditis and inflammatory cardiomyopathy: microbiological andmolecular biological aspects. Cardiovasc Res 60:11–25

    Article  PubMed  CAS  Google Scholar 

  • D’Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85:499–504

    Article  PubMed  CAS  Google Scholar 

  • Dec GW, Fuster V (1994a) Idiopathic dilated cardiomyopathy [see comments]. N Engl J Med 331:1564–1575

    Article  PubMed  CAS  Google Scholar 

  • Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-b in coxsackievirus B3 infection. Circulation 110:3540–3543

    Article  PubMed  CAS  Google Scholar 

  • Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863

    Article  PubMed  Google Scholar 

  • Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A (2000) Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36:1920–1926

    Article  PubMed  CAS  Google Scholar 

  • Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64:1235–1245

    PubMed  CAS  Google Scholar 

  • Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84:6272–6276

    Article  PubMed  CAS  Google Scholar 

  • Kanzaki Y, Terasaki F, Okabe M, Hayashi T, Toko H, Shimomura H, Fujioka S, Kitaura Y, Kawamura K, Horii Y, Isomura T, Suma H (2001) Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy. Jpn Circ J 65:797–802

    Article  PubMed  CAS  Google Scholar 

  • Karjalainen J, Heikkila J (1999) Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J 20:1120–1125

    Article  PubMed  CAS  Google Scholar 

  • Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295–300

    PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Schultheiss HP (1997a) [Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation]. Internist (Berl) 38:590–601

    Article  PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Schultheiss HP (1997b) Neue Konzepte zur Diagnostik der entzündlichen Herzmuskelerkrankung [Newconcepts in the diagnosis of inflammatory myocardial disease (see comments)]. Dtsch Med Wochenschr 122:690–698

    Article  PubMed  Google Scholar 

  • Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck PL, Seeberg B, Krautwurm L, Schulthei HP, Kandolf R (2003a) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:945–950

    Article  PubMed  CAS  Google Scholar 

  • Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003b) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793–2798

    Article  PubMed  CAS  Google Scholar 

  • Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893

    Article  PubMed  Google Scholar 

  • Li E, Brown SL, Von Seggern DJ, Brown GB, Nemerow GR (2000) Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery. Gene Ther 7:1593–1599

    Article  PubMed  CAS  Google Scholar 

  • Mason JW (2002) Viral latency: a link between myocarditis and dilated cardiomyopathy? J Mol Cell Cardiol 34:695–698

    Article  PubMed  CAS  Google Scholar 

  • Mason JW, JB OC, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators [see comments]. N Engl J Med 333:269–275

    Article  PubMed  CAS  Google Scholar 

  • Matsumori A (2001) Hepatitis C virus and cardiomyopathy. Intern Med 40:78–79

    PubMed  CAS  Google Scholar 

  • Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99:2124–2131

    PubMed  CAS  Google Scholar 

  • Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller AB, Pauschinger M, Bergelson J, Warraich R, Yacoub M, Hetzer R, Lamers J, Schultheiss HP, Poller W (2001) Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104:275–280

    PubMed  CAS  Google Scholar 

  • Noutsias M, Pauschinger M, Ostermann K, Escher F, Blohm JH, Schultheiss H, Kühl U (2002a) Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 8:MT59–71

    PubMed  CAS  Google Scholar 

  • Noutsias M, Pauschinger M, Schultheiss H, Kühl U (2002b) Phenotypic characterization of infiltrates in dilated cardiomyopathy — diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit 8:CR478–CR487

    PubMed  Google Scholar 

  • Noutsias M, Pauschinger M, Schultheiss HP, Kühl U (2003a) Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J 4:154–162

    Google Scholar 

  • Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kühl U (2003b) Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 3:127–135

    PubMed  Google Scholar 

  • Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kühl U (2004) Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives. Expert Rev Cardiovasc Ther 2:37–51

    Article  PubMed  CAS  Google Scholar 

  • Olbrich HG (2001) [Epidemiology-etiology of dilated cardiomyopathy]. Z Kardiol 90Suppl 1:2–9

    Article  PubMed  Google Scholar 

  • Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP (1999a) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895

    PubMed  CAS  Google Scholar 

  • Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kühl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999b) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348–1354

    PubMed  CAS  Google Scholar 

  • Pauschinger M, Chandrasekharan K, Noutsias M, Kühl U, Schwimmbeck LP, Schultheiss HP (2004) Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies. Med Microbiol Immunol (Berl) 193:65–69

    Article  PubMed  CAS  Google Scholar 

  • Poller W, Fechner H, Noutsias M, Tschoepe C, Schultheiss HP (2002) Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy. Z Kardiol 91:978–991

    Article  PubMed  CAS  Google Scholar 

  • Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, J OC, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [news]. Circulation 93:841–842

    PubMed  CAS  Google Scholar 

  • Shanes JG, Ghali J, Billingham ME, Ferrans VJ, Fenoglio JJ, Edwards WD, Tsai CC, Saffitz JE, Isner J, Furner S, et al. (1987) Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75:401–405

    PubMed  CAS  Google Scholar 

  • Towbin JA, Bowles NE (2000) Genetic abnormalities responsible for dilated cardiomyopathy. Curr Cardiol Rep 2:475–480

    PubMed  CAS  Google Scholar 

  • Towbin JA, Bowles NE (2001) Molecular genetics of left ventricular dysfunction. Curr Mol Med 1:81–90

    Article  PubMed  CAS  Google Scholar 

  • Towbin JA, Bowles NE (2002) Molecular diagnosis of myocardial disease. Expert Rev Mol Diagn 2:587–602

    Article  PubMed  CAS  Google Scholar 

  • Why HJ, Archard LC, Richardson PJ (1994a) Dilated cardiomyopathy-new insights into the pathogenesis. Postgrad Med J 70:S2–7

    PubMed  Google Scholar 

  • Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC (1994b) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582–2589

    PubMed  CAS  Google Scholar 

  • Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Pneumology, Campus Benjamin Franklin, Charité University Medicine Berlin, Hindenburgdamm 30, Germany

    H. -P. Schultheiss & U. Kühl

Authors
  1. H. -P. Schultheiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Kühl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology and Pneumology, Campus Benjamin Franklin, Charité University Medicine Berlin, Hindenburgdamm 30, Germany

    H. -P. Schultheiss

  2. Specialized Therapeutics, M1/3-9, Berlex Inc., Montville, NJ, 07045, USA

    J. -F. Kapp

  3. Medical Development, Specialized Therapeutics, Cardiovascular Europe, Schering AG, 13342, Berlin, Germany

    G. Grötzbach

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schultheiss, H.P., Kühl, U. (2006). Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis. In: Schultheiss, H.P., Kapp, J.F., Grötzbach, G. (eds) Chronic Viral and Inflammatory Cardiomyopathy. Ernst Schering Research Foundation Workshop, vol 55. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30822-9_1

Download citation

  • DOI: https://doi.org/10.1007/3-540-30822-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23971-0

  • Online ISBN: 978-3-540-30822-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation